Latest Breaking News On - Hematologic oncology - Page 1 : vimarsana.com

Physician Advocate: Healing During the AIDS Epidemic

Dr Koehne on the Use of Chemotherapy-Only Conditioning Regimens in Hematologic Malignancies

RGI-2001 Plus Tacrolimus/Methotrexate Demonstrates Protective Effect From Acute GVHD Post Allo-HSCT

Prophylactic treatment with RGI-2001 plus tacrolimus and methotrexate led to a lower incidence of acute GVHD vs CIBMTR control following allo-HSCT.

Dr Brown on the Potential for Pirtobrutinib to Address Treatment Discontinuation in CLL

Jennifer R. Brown, MD, PhD, discusses how pirtobrutinib may address BTK inhibitor discontinuation in chronic lymphocytic leukemia.

Dr Koehne on Efforts to Overcome CAR T-Cell Resistance in Hematologic Malignancies

Guenther Koehne, MD, PhD, discusses research efforts to overcome resistance to CAR T-cell therapy in hematologic malignancies.

Dr Brown on the Implications of Genomic Data for Pirtobrutinib Use in CLL

Jennifer R. Brown, MD, PhD, discusses results from a genomic analysis of responses with pirtobrutinib in patients with chronic lymphocytic leukemia.

Brentuximab Vedotin Plus Lenalidomide and Rituximab Generates OS Benefit in Previously Treated DLBCL

Brentuximab vedotin/lenalidomide/rituximab led to an OS improvement vs lenalidomide/rituximab/placebo in relapsed/refractory diffuse large B-cell lymphoma.

Chickasha transplant survivor urges congress to act, following cancer research breakthrough

A local transplant survivor ispreparing to head to Congress Feb. 26-28 to ask for more support to recruit young adults to become bone marrow donors after a cancer research breakthrough.

Kansas nurse heads to D.C. to urge support after cancer research breakthrough

Caprice on Racial and Ethnic Disparities in Transplant Outcomes in Hematologic Malignancies

Teresa Caprice, PA-C, discusses the use of post-transplant cyclophosphamide to address disparities in transplant outcomes in racial and ethnic populations.